Skip to main content

Table 1 Baseline characteristics of enrolled subjects according to study cohort (treatments received AL and ASAQ) at various sites in Mozambique

From: In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique

 

Study cohort 1 (AL)

Study cohort 2 (AS-AQ)

Variable

N = 439

N = 261

Female gender n (%)

197 (45)

137 (52)

Age in years (mean ± SD)

2.5 ± 1.2

2.5 ± 1.3

Weight in kg (mean ± SD)

11.8 ± 2.9

12.2 ± 3.7

Fever n (%)

319 (73)

201 (77)

Temperature in°C (mean ± SD)

38.0 ± 1.0

38.1 ± 0.9

Parasite density geometric mean (range)

30,094 (2,178-19,0011)

34,055 (2,417-213,394)

Hb in g/dL (mean ± SD)

9.2 ± 2.0

9.0 ± 1.8